Comparing Stigma and HIV Outcomes Between Transgender and Cisgender Women Sex Workers Living with HIV in the Dominican Republic.

Tamar Goldenberg, Tahilin Karver, Deanna Kerrigan, Hoisex Gomez, Martha Perez, Yeycy Donastorg, Clare Barrington
Author Information
  1. Tamar Goldenberg: Department of Public Health Education, School of Health and Human Sciences, University of North Carolina at Greensboro, Greensboro, North Carolina, USA.
  2. Tahilin Karver: Department of Prevention and Community Health, Milken Institute School of Public Health, George Washington University, Washington, District of Columbia, USA. ORCID
  3. Deanna Kerrigan: Department of Prevention and Community Health, Milken Institute School of Public Health, George Washington University, Washington, District of Columbia, USA.
  4. Hoisex Gomez: HIV Vaccine Research Unit, Instituto Dermatológico y Cirugía de Piel Dr. Huberto Bogaert Díaz, Santo Domingo, Dominican Republic.
  5. Martha Perez: HIV Vaccine Research Unit, Instituto Dermatológico y Cirugía de Piel Dr. Huberto Bogaert Díaz, Santo Domingo, Dominican Republic.
  6. Yeycy Donastorg: HIV Vaccine Research Unit, Instituto Dermatológico y Cirugía de Piel Dr. Huberto Bogaert Díaz, Santo Domingo, Dominican Republic.
  7. Clare Barrington: Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

Abstract

Purpose: Using an intersectionality framework, we compared stigma and HIV care and treatment outcomes across transgender and cisgender women sex workers living with HIV in the Dominican Republic (DR).
Methods: In 2018-2019, data were collected in Santo Domingo, DR, using interviewer-administered surveys among 211 cisgender women and 100 transgender women. We used -tests and chi-square tests to examine differences in sex work stigma, HIV stigma, and HIV care and treatment.
Results: Transgender participants reported more anticipated HIV stigma (mean=13.61, standard deviation [SD]=2.39) than cisgender participants (mean=12.96, SD=2.21; =0.018), but there were no statistically significant differences for internalized or enacted HIV stigma. Cisgender participants reported more anticipated sex work stigma (cisgender: mean=50.00, SD=9.22; transgender: mean=44.02, SD=9.54; <0.001), but transgender women reported more enacted (cisgender: mean=49.99, SD=9.11; transgender: mean=59.93, SD=4.89; <0.001) and internalized sex work stigma (cisgender: mean=50.00, SD=8.80; transgender: mean=57.84, SD=8.34; <0.001), with no significant differences in resistance to sex work stigma. Cisgender women were significantly more likely to have received HIV care (cisgender: 99.53%, transgender: 91.00%, <0.001), be currently taking antiretroviral therapy (cisgender: 96.21%, transgender: 84.00%, <0.001), and be virally suppressed (cisgender: 76.19%, transgender: 64.00%, =0.025).
Conclusions: Transgender participants consistently had poorer HIV care and treatment outcomes compared with cisgender participants. Differences in stigma experiences between transgender and cisgender participants depended on the type of stigma. Findings reflect the intersectional nature of distinct types and forms of stigma among sex workers. Understanding the shared and unique experiences of transgender and cisgender women will improve HIV care engagement and viral suppression.

Keywords

References

  1. AIDS Behav. 2021 Nov;25(Suppl 2):175-188 [PMID: 33730252]
  2. BMJ. 2009 Aug 11;339:b2939 [PMID: 19671935]
  3. AIDS Behav. 2010 Apr;14(2):351-8 [PMID: 19763812]
  4. Sociol Health Illn. 2016 Sep;38(7):1137-50 [PMID: 27113456]
  5. PLoS One. 2020 Jun 12;15(6):e0234666 [PMID: 32530939]
  6. Glob Public Health. 2016 Aug-Sep;11(7-8):835-48 [PMID: 26785751]
  7. Transgend Health. 2016 Sep 01;1(1):172-180 [PMID: 28861530]
  8. AIDS Care. 2012;24(7):846-55 [PMID: 22272891]
  9. Am J Public Health. 2012 Jul;102(7):1267-73 [PMID: 22594719]
  10. BMC Public Health. 2012 Apr 20;12:292 [PMID: 22520027]
  11. Cult Health Sex. 2017 May;19(5):543-556 [PMID: 27760507]
  12. PLoS One. 2014 Feb 14;9(2):e88157 [PMID: 24551079]
  13. Int J Transgend. 2019 Apr 23;20(4):403-412 [PMID: 32999625]
  14. Psychol Bull. 2009 Sep;135(5):707-730 [PMID: 19702379]
  15. Transgend Health. 2016 Dec 01;1(1):279-290 [PMID: 28861542]
  16. Glob Public Health. 2017 Dec;12(12):1506-1521 [PMID: 26999251]
  17. Stigma Health. 2021 Nov;6(4):467-475 [PMID: 36910276]
  18. AIDS Patient Care STDS. 2019 Jul;33(7):308-322 [PMID: 31260342]
  19. Soc Sci Med. 2015 Dec;147:222-31 [PMID: 26599625]
  20. Lancet. 2016 Jul 23;388(10042):412-436 [PMID: 27323919]
  21. AIDS Care. 2017 Jun;29(6):675-685 [PMID: 27998178]
  22. Transgend Health. 2016 Jul 01;1(1):137-141 [PMID: 29159304]
  23. Soc Sci Med. 2008 Feb;66(4):911-21 [PMID: 18155336]
  24. AIDS Behav. 2021 Sep;25(9):2941-2950 [PMID: 33511496]
  25. PLoS One. 2017 Nov 2;12(11):e0186457 [PMID: 29095843]
  26. AIDS Behav. 2013 Oct;17(8):2597-603 [PMID: 23525789]
  27. AIDS Patient Care STDS. 2013 Nov;27(11):621-7 [PMID: 24138486]
  28. BMC Med. 2019 Feb 15;17(1):7 [PMID: 30764816]
  29. J Acquir Immune Defic Syndr. 2015 Jun 1;69(2):216-22 [PMID: 25714246]
  30. Res Nurs Health. 2001 Dec;24(6):518-29 [PMID: 11746080]
  31. AIDS Behav. 2012 Jan;16(1):214-24 [PMID: 21538082]
  32. Suicide Life Threat Behav. 2018 Dec;48(6):788-796 [PMID: 28950402]
  33. Transgend Health. 2018 Dec 28;3(1):239-250 [PMID: 30623022]
  34. Afr J AIDS Res. 2016 Dec;15(4):377-386 [PMID: 27974017]
  35. AIDS Behav. 2015 Apr;19(4):715-22 [PMID: 25566761]
  36. Transgend Health. 2021 Jun 02;6(3):148-155 [PMID: 34414270]
  37. Lancet Infect Dis. 2013 Mar;13(3):214-22 [PMID: 23260128]
  38. Int J Transgend. 2015;16(4):209-221 [PMID: 27110227]
  39. J Acquir Immune Defic Syndr. 2018 Dec 1;79(4):413-420 [PMID: 30080750]

Word Cloud

Created with Highcharts 10.0.0stigmaHIVsextransgendercisgenderwomenparticipantscisgender:transgender:carework<0001treatmentDominicanRepublicdifferencesTransgenderreportedCisgenderSD=900%comparedoutcomesworkersDRamonganticipated96=0significantinternalizedenactedmean=500099SD=884experiencesPurpose:UsingintersectionalityframeworkacrosslivingMethods:2018-2019datacollectedSantoDomingousinginterviewer-administeredsurveys211100used-testschi-squaretestsexamineResults:mean=1361standarddeviation[SD]=239mean=12SD=221018statistically22mean=440254mean=4911mean=5993SD=48980mean=5734resistancesignificantlylikelyreceived53%91currentlytakingantiretroviraltherapy21%virallysuppressed7619%64025Conclusions:consistentlypoorerDifferencesdependedtypeFindingsreflectintersectionalnaturedistincttypesformsUnderstandingshareduniquewillimproveengagementviralsuppressionComparingStigmaOutcomesWomenSexWorkersLivingcomparativeanalysis

Similar Articles

Cited By